Intraoperative Methadone in Spinal Fusion: Modest Early Benefit, Unresolved Safety
This focused meta-analysis of five randomized trials in instrumented spinal fusion quantifies a modest, early analgesic and opioid-sparing effect of a single intravenous methadone dose while exposing the thin safety evidence that stewardship pharmacists must weigh.
📅 Journal publication: Oct 30, 2026·Last updated: Nov 17, 2026
Methadone may reduce post-surgery pain in spinal fusion.
Methadone may provide extended pain relief and reduce opioid use in spinal fusion surgery. Methadone reduced pain scores at 24-72 hours and opioid consumption at 24 hours but showed uncertain clinical importance. The findings are limited by small trial sizes and low certainty in outcomes, suggesting methadone is not yet routine. Methadone offers a possible optional benefit in multimodal analgesia for spinal fusion.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Abu-Zaid A, Alhajri RB, Alsuhail GH, Alabkal FR, Boshehri FY, Alshammari MA, Alajmi NA, Albarrak BA, Alzufairi OF, Alenezi AF, Alhuwaimel YT, Alabdullah AK, Alharran AM
Citation:Abu-Zaid A, Alhajri RB, Alsuhail GH, et al. Intraoperative Intravenous Methadone Versus Non-Methadone Opioid Analgesia in Instrumented Spinal Fusion: A GRADE-Guided Systematic Review and Meta-Analysis. Journal of clinical medicine. 2026;15(21). doi:10.3390/jcm15218470